BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1144 related articles for article (PubMed ID: 15493516)

  • 21. Inference of regulatory networks with a convergence improved MCMC sampler.
    Agostinho NB; Machado KS; Werhli AV
    BMC Bioinformatics; 2015 Sep; 16():306. PubMed ID: 26399857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population pharmacokinetic reanalysis of a Diazepam PBPK model: a comparison of Stan and GNU MCSim.
    Tsiros P; Bois FY; Dokoumetzidis A; Tsiliki G; Sarimveis H
    J Pharmacokinet Pharmacodyn; 2019 Apr; 46(2):173-192. PubMed ID: 30949914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel Gibbs maximum a posteriori (GMAP) approach on Bayesian nonlinear mixed-effects population pharmacokinetics (PK) models.
    Kim S; Hall SD; Li L
    J Biopharm Stat; 2009 Jul; 19(4):700-20. PubMed ID: 20183435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Searching for convergence in phylogenetic Markov chain Monte Carlo.
    Beiko RG; Keith JM; Harlow TJ; Ragan MA
    Syst Biol; 2006 Aug; 55(4):553-65. PubMed ID: 16857650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Markov chain Monte Carlo methods in biostatistics.
    Gelman A; Rubin DB
    Stat Methods Med Res; 1996 Dec; 5(4):339-55. PubMed ID: 9004377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonparametric identification of population models: an MCMC approach.
    Neve M; De Nicolao G; Marchesi L
    IEEE Trans Biomed Eng; 2008 Jan; 55(1):41-50. PubMed ID: 18232345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model.
    Gibiansky L; Gibiansky E; Bauer R
    J Pharmacokinet Pharmacodyn; 2012 Feb; 39(1):17-35. PubMed ID: 22101761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling attainment of steady state of drug concentration in plasma by means of a Bayesian approach using MCMC methods.
    Jordan P; Brunschwig H; Luedin E
    Pharm Stat; 2008; 7(1):36-41. PubMed ID: 17335108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parallel Metropolis coupled Markov chain Monte Carlo for Bayesian phylogenetic inference.
    Altekar G; Dwarkadas S; Huelsenbeck JP; Ronquist F
    Bioinformatics; 2004 Feb; 20(3):407-15. PubMed ID: 14960467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An example of complex modelling in dentistry using Markov chain Monte Carlo (MCMC) simulation.
    Helfenstein U; Menghini G; Steiner M; Murati F
    Community Dent Health; 2002 Sep; 19(3):152-60. PubMed ID: 12269461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models.
    Hack CE
    Toxicology; 2006 Apr; 221(2-3):241-8. PubMed ID: 16466842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A simple introduction to Markov Chain Monte-Carlo sampling.
    van Ravenzwaaij D; Cassey P; Brown SD
    Psychon Bull Rev; 2018 Feb; 25(1):143-154. PubMed ID: 26968853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Population forecasts for Bangladesh, using a Bayesian methodology.
    Mahsin M; Hossain SS
    J Health Popul Nutr; 2012 Dec; 30(4):456-63. PubMed ID: 23304912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Connecting PM and MAP in Bayesian spectral deconvolution by extending exchange Monte Carlo method and using multiple data sets.
    Motonaka K; Miyoshi S
    Neural Netw; 2019 Oct; 118():159-166. PubMed ID: 31279286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hierarchical Bayesian estimates of distributed MEG sources: theoretical aspects and comparison of variational and MCMC methods.
    Nummenmaa A; Auranen T; Hämäläinen MS; Jääskeläinen IP; Lampinen J; Sams M; Vehtari A
    Neuroimage; 2007 Apr; 35(2):669-85. PubMed ID: 17300961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GSEVM v.2: MCMC software to analyze genetically structured environmental variance models.
    Ibáñez-Escriche N; Garcia M; Sorensen D
    J Anim Breed Genet; 2010 Jun; 127(3):249-51. PubMed ID: 20536643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using Bayesian inference to estimate plausible muscle forces in musculoskeletal models.
    Johnson RT; Lakeland D; Finley JM
    J Neuroeng Rehabil; 2022 Mar; 19(1):34. PubMed ID: 35321736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On the reliability of NMR relaxation data analyses: a Markov Chain Monte Carlo approach.
    Abergel D; Volpato A; Coutant EP; Polimeno A
    J Magn Reson; 2014 Sep; 246():94-103. PubMed ID: 25117152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploring heterogeneity in tumour data using Markov chain Monte Carlo.
    de Gunst MC; Dewanji A; Luebeck EG
    Stat Med; 2003 May; 22(10):1691-707. PubMed ID: 12720305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Hierarchical Multi-Unidimensional IRT Approach for Analyzing Sparse, Multi-Group Data for Integrative Data Analysis.
    Huo Y; de la Torre J; Mun EY; Kim SY; Ray AE; Jiao Y; White HR
    Psychometrika; 2015 Sep; 80(3):834-55. PubMed ID: 25265910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 58.